Search

everythinglearnresearchcommunity

for

Search:↓

Stem cell activity influences autoimmune disease outcomes by affecting immune responses and tissue regeneration.

Mechlorethamine treatment regrew hair in mice by killing immune cells causing hair loss without harming hair follicles.

LiPADI is a useful tool for monitoring the severity and treatment of lichen planus.

Autoimmune diseases with high tissue recovery often relapse and remit, while those with low recovery rarely remit.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

Different types of alopecia cause hair loss due to immune system issues, with some allowing regrowth and others causing permanent loss.

Hair loss in Cronkhite-Canada syndrome may be caused by autoimmune factors, not just stress or malabsorption.

Targeted immune modulation can help achieve stable remission in alopecia areata.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

No single treatment is consistently effective for alopecia areata, and more research is needed.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

Children with alopecia areata have immune imbalances and are more likely to have certain health issues.

BIVV009 is a safe treatment for bullous pemphigoid that reduces C3 deposition without harmful side effects.

Treating ovarian-related inflammation may help hair regrowth in women with alopecia areata.

PRP can help hair growth in some types of hair loss.

BAFF-targeted therapies can reduce autoimmune disease activity, but more research is needed for precise treatments.

The herbal mix of hibiscus and vitex shows promise for treating autoimmune diseases due to its effectiveness and low toxicity.

Hair changes may indicate disease activity in pemphigus patients.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Bacteroides fragilis and Microbacterium sp. T32 may be linked to autoimmune activity in Hashimoto's thyroiditis and alopecia areata.

MDSC-Exo can treat autoimmune alopecia areata and promote hair regrowth in mice.

Autoimmune diseases can change hair texture, but treatment can restore it.

A specific gene change is linked to severe hair loss.

Cepharanthine has many medicinal uses but needs improvement for better effectiveness.

Simvastatin helps hair regrowth in autoimmune alopecia by directly affecting T cells.

Elevated granulysin levels may indicate disease activity in vitiligo and alopecia areata.

Platelet-rich plasma treatments reduce knee osteoarthritis inflammation, with pure PRP being more effective.

Hair loss is common in autoimmune diseases and can be an early sign of the condition, often requiring prompt treatment to prevent permanent damage.

PRP is a promising treatment for autoimmune hair loss but its exact workings are not fully understood.